Northrop Grumman (NOC) Stock Forecast & Price Target

Northrop Grumman is well positioned because its B-21 and Sentinel franchises are moving from development into production, creating durable revenue visibility and an improving margin profile as later awards are negotiated on better terms. The company’s 2026 organic growth guidance of about MSD%, segment margins near 11.3%, and the expected acceleration in Defense Systems, Space, and international sales support a stronger top-line mix even though its 2028 CAGR forecasts trail peers. Its valuation is underpinned by a broad backlog and funding backdrop, including roughly $35 billion of Defense Systems backlog, about $26.2 billion of Space Systems backlog, and management’s plan to double international sales to about $10 billion by 2031.

Northrop Grumman is viewed negatively because its growth profile now looks only roughly in line with peers, with about 6% top-line growth through 2028 already largely embedded in expectations and no clear catalyst to re-rate the stock. The outlook is further constrained by slower post-FY27 defense budget growth, limited international exposure, incremental F-35 risk, and the loss of the Navy’s F/A-XX contract, while B-21 investments and fixed-price LRIP losses create near-term margin pressure. On the financial side, the company’s 2028 free cash flow estimate of $3.6B, a 21x valuation framework, and roughly $2.04B of cumulative disclosed B-21 LRIP losses reinforce the view that upside is limited and capital returns are less likely to drive earnings growth.